These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25820533)

  • 1. Safety of antidiabetes medications: An update.
    Bailey CJ
    Clin Pharmacol Ther; 2015 Aug; 98(2):185-95. PubMed ID: 25820533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A safety evaluation of canagliflozin : a first-in-class treatment for type 2 diabetes.
    Boyle LD; Wilding JP
    Expert Opin Drug Saf; 2014 Nov; 13(11):1535-44. PubMed ID: 25340618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose products.
    Berg EG
    Diabetes Forecast; 2014 Jan; 67(1):76-7. PubMed ID: 25868301
    [No Abstract]   [Full Text] [Related]  

  • 4. Type 2 Diabetes: Progress Made but Still a Long Road to Travel to Reduce Disease Burden.
    Terra SG; Vincent J
    Clin Pharmacol Ther; 2015 Aug; 98(2):108-11. PubMed ID: 26013760
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on Management of Type 2 Diabetes for Cardiologists.
    Qureshi M; Gammoh E; Shakil J; Robbins R
    Methodist Debakey Cardiovasc J; 2018; 14(4):273-280. PubMed ID: 30788013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Innovations.
    Curry A
    Diabetes Forecast; 2015; 68(4):38-43. PubMed ID: 26374923
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin degludec--the impact of a new basal insulin on care in type 2 diabetes.
    Khunti K; Cos X; Rutten G
    Prim Care Diabetes; 2014 Jul; 8(2):119-25. PubMed ID: 24207030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iixisenatide. Wait for conclusive results on complications of diabetes.
    Prescrire Int; 2014 Oct; 23(153):234-5. PubMed ID: 25964965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risks and benefits with oral drugs for Type 2 diabetes mellitus.
    Weidman-Evans E; Metz SM; Evans JD
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):225-33. PubMed ID: 24490745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are We There Yet?
    Tsai A
    Diabetes Forecast; 2016; 69(1):52-7. PubMed ID: 26983288
    [No Abstract]   [Full Text] [Related]  

  • 11. ORIGIN trial shows safety and efficacy of insulin glargine: no adverse cardiovascular outcomes after a 6.2-year follow up of early insulin use.
    Lombard L; Distiller L; Aalbers J
    Cardiovasc J Afr; 2012 Jul; 23(6):357-8. PubMed ID: 23091824
    [No Abstract]   [Full Text] [Related]  

  • 12. The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future.
    Bailey CJ
    Clin Pharmacol Ther; 2015 Aug; 98(2):170-84. PubMed ID: 25963904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes.
    Herman ME; O'Keefe JH; Bell DSH; Schwartz SS
    Prog Cardiovasc Dis; 2017; 60(3):422-434. PubMed ID: 28958751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes: assessing the relative risks and benefits of glucose-lowering medications.
    Bergenstal RM; Bailey CJ; Kendall DM
    Am J Med; 2010 Apr; 123(4):374.e 9 -18. PubMed ID: 20362759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA).
    Rehani PR; Iftikhar H; Nakajima M; Tanaka T; Jabbar Z; Rehani RN
    J Diabetes Res; 2019; 2019():4267357. PubMed ID: 31781665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes: Time for reconciliation between cardiologists and diabetologists.
    Scheen AJ
    Nat Rev Cardiol; 2016 Sep; 13(9):509-10. PubMed ID: 27411401
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycemia Lowering and Risk for Heart Failure: Recent Evidence from Studies of Dipeptidyl Peptidase Inhibition.
    Zhong J; Goud A; Rajagopalan S
    Circ Heart Fail; 2015 Jul; 8(4):819-25. PubMed ID: 26199308
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral drugs for diabetes--update of current use and availability].
    Niskanen L
    Duodecim; 2004; 120(8):983-90. PubMed ID: 15185512
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk.
    Peters AL
    Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S20-7. PubMed ID: 19952300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing treatment for patients with diabetes mellitus: glycemic and nonglycemic effects.
    Shubrook JH
    J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):Sii-1. PubMed ID: 21928545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.